Showing results (171-180 of 193) with videos related to

Sort By:
Pageof 20
Human Molecular Genetics|September 23, 2016
Modulating ryanodine receptors with dantrolene attenuates neuronopathic phenotype in Gaucher disease miceBenjamin Liou, Yanyan Peng, Ronghua Li, et al.
Molecular Genetics and Metabolism|September 16, 2014
CNS, lung, and lymph node involvement in Gaucher disease type 3 after 11 years of therapy: clinical, histopathologic, and biochemical findingsThomas A Burrow, Ying Sun, Carlos E Prada, et al.
Molecular Therapy : the Journal of the American Society of Gene Therapy|March 8, 2016
CNS-accessible Inhibitor of Glucosylceramide Synthase for Substrate Reduction Therapy of Neuronopathic Gaucher DiseaseJohn Marshall, Ying Sun, Dinesh S Bangari, et al.
Science (New York, N.Y.)|December 20, 2003
Editing of CD1d-bound lipid antigens by endosomal lipid transfer proteinsDapeng Zhou, Carlos Cantu, Yuval Sagiv, et al.
BMC Medical Genetics|October 25, 2008
Multiple interactions between the alpha 2C- and beta1-adrenergic receptors influence heart failure survivalSharon L R Kardia, Reagan J Kelly, Mehdi A Keddache, et al.
Nature|February 23, 2017
Complement drives glucosylceramide accumulation and tissue inflammation in Gaucher diseaseManoj K Pandey, Thomas A Burrow, Reena Rani, et al.
Pageof 20